PHIP and colorectal cancer: Blocking DNMT3B leads to reduced methylation of the E3 ligase PhIP promoter, which increases PhIP transcription, promotes CDK2 ubiquitination and degradation, and finally leads to the growth arrest of colorectal cancer cells in the G0/G1 phase.